Loading viewer...
investor_presentation
Format: PDF investor_presentation
Clinical-stage regenerative medicine company presenting 2016 financial results and 2017 strategic transformation. Focuses on development of implant products, bioreactors, and scaffolds for esophagus and airway applications with $8.0 million in funding closed February 2017.
earnings
11 Pages
investor_presentation
34 Pages
Alarko Holding
Atlantica Sustainable Infrastructure Investor Presentation — January 2022
investor_presentationinvestor_presentation
8 Pages
Atlantica Sustainable Infrastructure